Date: 2013-01-08
Type of information: Services contract
Compound:
Company: Octoplus (The Netherlands) Sanofi (France)
Therapeutic area:
Type agreement: services
Action mechanism:
Disease:
Details: OctoPlus has announced that a Master Service Agreement has been signed with Sanofi. This Master Service Agreement follows a successful collaboration in ongoing development of a number of formulations which has made and will make a material contribution to OctoPlus’ 2012 and 2013 revenues. Further details on the compound and activities are not disclosed.
Financial terms:
Latest news:
